Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Surrozen, Inc. , a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

52W Range

47thpctl

Volume

1.43×avg

Market Cap

167.64MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Surrozen, Inc.

SRZNNASDAQ Capital Market·USD·Closed

Surrozen, Inc.

SRZNNASDAQ·USD·Closed

$22.42

−6.62%

$22.42

−$1.59 (6.62%)

52W Range

47thpctl

Volume

1.43×avg

Mkt Cap

167.64MUSD

P/E

-0.5TTM

Div Yield

–ann

SRZN: Surrozen, Inc. Stock Analysis | finqOS